MGLL and Alzheimer disease: Comparable effects have been noted in rodent models of AD, where the stimulation of the CB2 receptor or inhibition of MAGL resulted in Aβ reduction in the hippocampus and showed a significant improvement in cognitive function [89,91,92,93,94,95].